Not cruel, if we are to assume "all subjects will
Post# of 148185
From clinicaltrials.gov
"Arm A: CD24Fc/Best Available Treatment; Arm B: placebo/ Best Available Treatment. CD24Fc will be administered as single dose of 480 mg via IV infusion on Day 1. Total of 270 subjects will be enrolled and randomized in 1:1 ratio to receive CD24Fc or placebo. All subjects will be treated with the best available treatment. The follow up period is 28 days."
Unless I Don't Understand, gotta challenge the idea that the Merck therapeutic trial could give as placebo, only saline water, no SOC drugs (whatever they are currently.
How can they justify a s/c covid not getting SOC treatment? I must not be reading that correctly, that would be rather cruel.
Read More: https://investorshangout.com/post/newpost/605...z6hTsvRJbp